0 items

in your cart

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  • Click-to-Call  

Prescription Drug Search

Strengths available for Letairis:

Letairis 5mg
Letairis 10mg

Search for a drug:


Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about GlobalPharmacyMeds.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Letairis:

  • Algeria
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Bermuda
  • Bosnia and Herzegovina
  • Cayman Islands
  • Chile
  • China
  • Cook Islands
  • Costa Rica
  • Czech Republic
  • Georgia
  • Germany
  • Greece
  • Greenland
  • Guadeloupe
  • India
  • Iran
  • Iraq
  • Japan
  • Korea, Republic of
  • Kuwait
  • Lebanon
  • Lithuania
  • Mauritius
  • Netherlands Antilles
  • Panama
  • Portugal
  • Qatar
  • Romania
  • Saint Lucia
  • Serbia
  • Taiwan
  • Trinidad and Tobago
  • United Kingdom, UK
  • United States, US
  • Vanuatu
View All Countries

Latest news releases on Letairis:

Letairis® (ambrisentan) | Official Patient Site

Letairis (ambrisentan) is a prescription medicine used to treat pulmonary arterial hypertension (PAH), which is high blood pressure in the arteries of the lungs.

Letairis (ambrisentan) Uses, Dosage, Side Effects - Drugs.com

Letairis (ambrisentan) prevents thickening of the blood vessels, especially those in the lungs and heart. Ambrisentan also lowers blood pressure in your lungs, helping your heart pump blood more efficiently.

Enroll a Patient | Letairis® (ambrisentan)

Updates to the Letairis patient enrollment process What has changed? Due to changes in the FDA-mandated REMS enrollment process, there are now two separate patient enrollment forms.


2 FULL PRESCRIBING INFORMATION WARNING: EMBRYO-FETAL TOXICITY Do not administer Letairis to a pregnant female because it may cause fetal harm.


THE AMBITION TRIAL Expert Presentation of the Use of Initial Combination Therapy in Pulmonary Arterial Hypertension (PAH) The AMBITION trial was the first and only long-term, event-driven, PAH outcomes trial designed to study the effects of initial combination therapy with Letairis® (ambrisentan) + tadalafil in treatment-naïve patients with ...

Overview of the Letairis REMS Program

Download Letairis REMS Materials. In order to ensure that Letairis is prescribed and taken safely, Gilead has worked with the FDA to develop materials for the Letairis REMS Program to inform prescribers and patients about the risk of serious birth defects.

U.S. Food and Drug Administration Approves New Treatment ...

-- First-Line Combination of Letairis and Tadalafil Reduced Risk of Disease Progression by Nearly 50 Percent Compared to Either Therapy Individually in Study of 605 PAH Patients with WHO Functional Class II-III Symptoms --

Letairis REMS Program - Home Page

The Letairis Risk Evaluation and Mitigation Strategy (REMS) Program A Risk Evaluation and Mitigation Strategy is a strategy to manage known or potential serious risks associated with a drug product and is required by the Food and Drug Administration (FDA) to ensure that the benefits of the drug outweigh its risks.

Initial Use of Ambrisentan plus Tadalafil in Pulmonary ...

n engl j med 373;9 nejm.orgAugust 27, 2015 835 Ambrisentan–Tadalafil in Pulmonary Arterial Hypertension R egardless of the initiating trig-ger, pulmonary arterial hypertension re-

LETAIRIS®: Specialty Pharmacy Information Center from ...

UnitedHealthcare will no longer maintain this site effective October 1, 2017. If you are a member, visit myuhc.com for details on your specialty pharmacy benefits and information regarding specialty medications.

Customer Service
1-866-799-3435 (Use ref# 10786) | Contact Form
Copyright © 2018 GlobalPharmacyMeds.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK